Tabelecleucel: A New Approach to Treating EBV-Positive Post-Transplant Lymphoproliferative Disease
A phase 3 study from earlier in 2024, reveals that Tabelecleucel could offer hope for transplant patients with EBV-positive PTLD, providing an alternative for those who haven’t responded to standard treatments.
Ageless Wonder: The Mother Who Credits Youthful Looks to Her Son’s Blood
A woman in her 30s claims to defy aging by using her son’s blood for regenerative treatments. This unconventional anti-aging practice has sparked conspiracy and debate in the medical community.
